Biblio
2022
Kambhampati S, Saumoy M, Schneider Y, Serrao S, Solaimani P, Budde LElizabeth, Mei MG, Popplewell L, Siddiqi T, Zain J, et al. Cost Effectiveness of Second-Line Axicabtagene ciloleucel in Relapsed Refractory Diffuse Large B-cell Lymphoma. Blood. 2022.